USP7-IN-13

• UNSPSC Description:

  USP7-IN-13 (Compound 101) is a USP7 inhibitor with an IC50 value of 0.2-1 μM, which can be used for the study of multiple myeloma[1].

• Target Antigen:

  Deubiquitinase

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/usp7-in-13.html

• Solubility:

  DMSO : 200 mg/mL (ultrasonic)

• Smiles:

  O=C1C2=CC=C(N)C=C2N=CN1CC3(CCN(CC3)C(C[C@H](C4=CC=CC=C4)C)=O)O

• Molecular Weight:

  420.50

• References & Citations:

  [1]Buhrlage, Sara, et al. "Novel usp7 inhibitors for treating multiple myeloma." U.S. Patent. WO2019067503. 2019-04-04

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2305046-93-7